Israel Englander Corcept Therapeutics Inc Call Options Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$29.51 - $46.26 $1.29 Million - $2.03 Million
43,800 Added 30.42%
187,800 $8.69 Million
Q2 2024

Aug 14, 2024
SELL
$22.21 - $34.48 $1.64 Million - $2.55 Million
-73,900 Reduced 33.91%
144,000 $4.68 Million
Q1 2024

May 15, 2024
BUY
$21.1 - $27.46 $4.6 Million - $5.98 Million
217,900 New
217,900 $5.49 Million

Others Institutions Holding CORT

# of Institutions
346
Shares Held
86.1M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.51B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email